Showing results (171-180 of 435) with videos related to

Sort By:
Pageof 44
Cells|October 15, 2025
A Change of Hallmark: An UpdateTom Donnem, David Kerr, Leonid L Nikitenko, et al.
Canadian Journal of Diabetes|December 3, 2014
Physiological and glycemic responses following acute ingestion of a popular functional drink in patients with type 1 diabetesTolulope Olateju, Joseph Begley, Daniel J Green, et al.
Journal of Gastrointestinal Cancer|July 8, 2026
Tumour-Associated Neutrophils in Colorectal Cancer: a Systematic Review, Meta-analysis, and Comprehensive Literature ReviewAna Beatriz Kinupe Abrahao, Tiago Cordeiro Felismino, David Kerr
Journal of Diabetes Science and Technology|October 28, 2022
Painful Diabetic Neuropathy: The Need for New ApproachesAndrea M Yeung, Jingtong Huang, Kevin T Nguyen, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 18, 2024
Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital DischargeGuillermo E Umpierrez, Iris Castro-Revoredo, Bobak Moazzami, et al.
Journal of Diabetes Science and Technology|May 8, 2026
Beyond the Mean: A Machine Learning-Based Trend Analysis of CGM Metrics for Improved HbA1C Estimation in Type 2 DiabetesCamilla H N Thomsen, Simon L Cichosz, Thomas Kronborg, et al.
European Journal of Endocrinology|June 9, 2020
ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovationDeborah J Wake, Fraser W Gibb, Partha Kar, et al.
Journal of Diabetes Science and Technology|November 11, 2025
Evaluating the Clinical Utility of the Glycemia Risk IndexAgatha F Scheideman, Mandy M Shao, Yijiong Yang, et al.
BMC Medical Informatics and Decision Making|November 27, 2024
Qualitative metrics from the biomedical literature for evaluating large language models in clinical decision-making: a narrative reviewCindy N Ho, Tiffany Tian, Alessandra T Ayers, et al.
Clinical Therapeutics|March 24, 2007
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trialsJohn B Buse, David C Klonoff, Loretta L Nielsen, et al.
Pageof 44